The long-term dynamics of serum antibodies against SARS-CoV-2Article Published on 2022-12-152023-07-11 Journal: PeerJ [Category] COVID19(2023년), [키워드] age antibody production COVID-19 patients Gender immune responses S-UFRJ SARS-CoV-2-specific antibodies Seroconversion Serologic response spike glycoprotein. [DOI] 10.7717/peerj.14547 PMC 바로가기
Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccinationArticle Published on 2022-11-012022-11-15 Journal: Journal of Immunological Methods [Category] SARS, 진단, 치료기술, 치료제, [키워드] Antibody Response Antigen antigenic target assays correlated COVID-19 IgG immune response increasingly Infection infection with SARS-CoV-2 measure measurement multiplex Multiplex assay nucleocapsid antigen performance platform Quantitative ranged RBD Receptor binding domain S1 and S2 SARS-CoV-2 SARS-COV-2 infection sensitivity serologic assay Serologic response Serology. specificity subunit vaccination Variation [DOI] 10.1016/j.jim.2022.113345 PMC 바로가기
Reduced B cell antigenicity of Omicron lowers host serologic responseArticle Published on 2022-10-182022-11-15 Journal: Cell Reports [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] Antibody Response Antibody titer antigenicity B cell Breakthrough infection common cold coronavirus computational structural biology conserved CP: Immunology CP: Microbiology cross-reactivity deep learning ELISA Epitopes evade explain feature geometric Host Infection less Lower mechanism Mice immunization experiment mutated Neutralizing omicron Omicron variant of concern RBD RBS Receptor binding Receptor binding domain receptor binding site reduced reduction reduction in reveal SARS-CoV-2 Serologic response serological response serum Spike protein spike protein. trajectory vaccine-induced antibody variant variants viral evolution [DOI] 10.1016/j.celrep.2022.111512 PMC 바로가기
Seroconversion and outcomes after initial and booster COVID-19 vaccination in adults with hematologic malignanciesArticle Published on 2022-09-152022-11-15 Journal: Cancer [Category] 진단, [키워드] active malignancy analyzed antibodies antibody association Asymptomatic booster booster dose booster vaccination Cancer coronavirus coronavirus disease Coronavirus disease-19 Course COVID-19 COVID-19 infection COVID-19 vaccination COVID-19-related death death decrease detectable diagnosed died effective eliminated Hematologic malignancy high-risk population humoral Humoral immunity immunization incidence of COVID-19 Infection initial lack less lowest lymphoma Lymphoma. malignancy monoclonal antibody occurred outcome outcomes Patient postvaccination promote Prophylactic proportion reduced response to vaccination revaccination risk risk of COVID-19 Seroconversion seroconversion rate Serologic response seronegative suggested the patient therapy treated Treatment undetectable vaccination Vaccine [DOI] 10.1002/cncr.34354 PMC 바로가기
Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With MyelomaArticle Published on 2022-09-102022-11-15 Journal: Journal of clinical oncology : official journal of [Category] SARS, 변종, 진단, 치료기술, [키워드] affected analyzed antibody B-cell malignancy BNT162b2 Booster vaccine Characteristics Critical Delta detect detectable determinant disease environmental exposure Factors greater hosts Immunocompromised implication increased risk induction initial lack Live virus Moderna MONITOR Mortality mRNA1273 much lower Multiple myeloma Myeloma NAb neutralization neutralize neutralizing antibody neutralizing capacity nucleocapsid Patient patients Pseudovirus neutralization assay quantified RBD receiving response SARS CoV-2 Seroconversion Serologic response significantly spike receptor-binding domain the vaccine Treatment vaccination Vaccine vaccine-induced antibody variant viral neutralization virus virus-neutralizing were measured [DOI] 10.1200/JCO.21.02257 PMC 바로가기
Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipientsArticle Published on 2022-09-092022-11-15 Journal: Vaccine [Category] SARS, 진단, [키워드] Abbott Diagnostics Ad5-nCoV Analysis analyzed applied blood sample BNT162b2 BNT162b2 vaccine ChAdOx1 China Comorbidity Complete Control controls CoronaVac COVID-19 COVID-19 vaccine DiaSorin Efficacy evaluate Gam-COVID-Vac healthy healthy controls humoral Humoral response IgG immunosuppressants Italy life liver median Mexico mRNA-1273 multivariable model Oxford-AstraZeneca Pandemia participant Patient patients Pfizer-BioNTech platform positive Prednisone recipient recipients reduced SARS-CoV-2 vaccine Serologic response serological response Sinovac USA vaccination Vaccine vaccine doses Vaccines. women [DOI] 10.1016/j.vaccine.2022.08.027 PMC 바로가기
SARS-CoV-2 Vaccine Response in Patients With Autoimmune HepatitisArticle Published on 2022-09-012022-11-15 Journal: Clinical gastroenterology and hepatology : the off [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory syndrome Autoimmune hepatitis China chronic liver disease Cohort coronavirus coronavirus disease death decrease disorder Europe glucocorticoid Hospitalization Immune-mediated Immunocompromised patients immunogenic inactivated incidence increased risk Inflammatory bowel disease Liver disease morbidity and mortality multicenter Patient provide reduce reduced response SARS-CoV-2 Serologic response shown the healthy vaccination vaccine-induced antibody variants of concern whole-virion SARS-CoV-2 vaccine [DOI] 10.1016/j.cgh.2022.04.006 PMC 바로가기
Predictors of poor serologic response to COVID-19 vaccine in patients with cancer: a systematic review and meta-analysisResearch article Published on 2022-09-012022-10-05 Journal: European journal of cancer (Oxford, England : 1990 [Category] 변종, [키워드] 95% confidence interval advanced age anti-CD20 therapy article Cancer Cancer patients cancer treatment Chemotherapy China cohort study Complete Concentration correlated Course COVID-19 vaccination COVID-19 vaccine database Endocrine Factor heterogeneity Immunotherapy inclusion criteria Infrastructure item male Meta-analysis metastatic disease Mutation no significant difference Odds ratio outcome Patient patients Patients with cancer predict predictor predictors Probability receiving Registered Relating reported Reporting Result review searched Seroconversion Serologic response statistical systematic review Treatment vaccination Vaccination strategy was used [DOI] 10.1016/j.ejca.2022.05.031 [Article Type] Research article
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell TransplantationArticle Published on 2022-09-012022-11-16 Journal: Transplantation and cellular therapy [Category] COVID19(2023년), SARS, 치료기술, [키워드] age Allogeneic allogeneic transplantation antibody Antibody Response average binding antibody unit Blood donors BNT162b2 chronic GVHD CORD COVID-19 detectable Donor dose Efficacy Graft-versus-host disease GVHD in vivo independent predictor initial involved JNJ-78436735 Johnson & Johnson less Lymphocyte count lymphocyte counts Moderna mRNA-1273 multivariable analysis Patient Predictive Prophylaxis question recipient recipients respond response robust SARS-CoV-2 spike protein SARS-CoV-2 vaccination Serologic response STEM stem cell Stem cell transplantation T cell depletion T-cell T-cell Depletion Transplant transplantation transplants umbilical cord blood vaccination vaccination. Vaccine [DOI] 10.1016/j.jtct.2022.06.012 PMC 바로가기
Factors affecting the serologic response to SARS-CoV-2 vaccination in patients with solid tumors: A prospective study고형암 환자에서 SARS-CoV-2 백신접종에 대한 혈청학적 반응에 영향을 미치는 요인: 전향적 연구Observational Study Published on 2022-09-012022-09-12 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] addition affecting analyzed Anti-SARS-CoV-2 S antibody antibody level Antibody test baseline blood sample BNT162b2 Cancer Chemotherapy CLIA clinical feature clinical study collected CoronaVac CoronaVac. COVID-19 demographic determine diagnoses dose enzyme evaluate Factor first dose IgG antibody IgG level immunoassay in both groups inactivated men mRNA vaccine of BNT162b2 oncology Patient Patients with cancer positive preventive measure proportion Prospective Study Quantitative RBD receiving Receptor binding domain SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV-2 PCR SARS-CoV-2 vaccination SARS-CoV-2 vaccine SARS-CoV-2 vaccines second dose Serologic response Sex significantly significantly higher single-center study solid tumor solid tumors vaccination Vaccine Vaccines virus spike protein was determined were excluded were measured [DOI] 10.1016/j.jiac.2022.05.021 PMC 바로가기 [Article Type] Observational Study